Navigation Links
Huge Drop in Preterm Birth-Risk Among Women Taking Folic Acid One Year Before Conception
Date:1/31/2008

Largest U.S. Study of Pre-conceptional Folic Acid Supplementation Receives March of Dimes Award

DALLAS, Jan. 31 /PRNewswire-USNewswire/ -- New research suggests that women who take folic acid supplements for at least one year before they become pregnant can cut their risk of having a premature baby by half.

Researchers at the 28th Annual Society for Maternal-Fetal Medicine (SMFM) meeting -- The Pregnancy Meeting(TM)-- today unveiled a study linking pre-conceptional folate supplementation of at least one year to reduced early premature delivery rates of 50 to 70 percent, regardless of age, race or other factors. Of particular note is the drop in very early premature births, those babies who are at the greatest risk of complications such as cerebral palsy, mental retardation, chronic lung disease, and blindness.

The study is an observational analysis based on the self-reporting of folate supplementation by 38,033 participants in an earlier trial sponsored by the National Institutes of Health (NIH.) The current study only examined singleton pregnancies and excluded pregnancies in which there were medical or obstetrical complications such as preeclampsia, chronic hypertension, and congenital or chromosomal abnormalities.

"Thanks to the depth and breadth of the NIH study, which included an early pregnancy ultrasound of each participant, we had highly accurate evidence of the gestational ages of the preterm deliveries," said Radek Bukowski, M.D., Ph.D., assistant professor, Obstetrics and Gynecology, at the University of Texas Medical Branch at Galveston, the lead study author and SMFM member. "This evidence enabled us to determine that folate supplementation for at least one year is linked to a 70 percent decrease in very early preterm deliveries (20 to 28 weeks in gestational age) and up to a 50 percent reduction in early preterm deliveries of 28 to 32 weeks."

"We already knew that folic acid supplementation beginning
'/>"/>

SOURCE March of Dimes
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
2. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
3. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in Miami
4. Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture
5. Smokefree Workplace Law Reduces Heart Attacks 59% Among Nonsmokers, New Research Shows
6. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
7. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
8. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 05, 2015 Research and Markets ( ... "Japan Pharma Outlook 2015: Year to Watch out for ... report to their offering. The new ... from April -2014 (Annexure 1) is a game changer ... generic or innovator. The most of the companies are ...
(Date:3/5/2015)... and HAMPTON, N.J. , ... (NYSE: MNK ), a leading global specialty ... company, announced today that they have entered into a ... acquire Ikaria, Inc. from a Madison Dearborn -led ... billion. Subject to customary closing conditions, ...
(Date:3/5/2015)... Mar. 05, 2015 Research and Markets ... "Global Rising Stars Outlook 2015" report to ... diseases are being sought after with fresh vigor as ... field which is poised to bring a paradigm change ... decades is the Stem cell therapy/Regenerative Medicine space. ...
Breaking Medicine Technology:Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Global Pharma Rising Stars Outlook 2015 2
... Corp. (the "Company") (PINKSHEETS: VSHC) announces that it has published ... on the OTC Markets site as well as on the ... Company is pleased to report that its 4th Quarter results ... moves toward establishing a stable position within the global Healthcare ...
... Genesis Biopharma, Inc. (OTCBB: GNBP), a biotechnology company ... of four senior industry consultants. "These ... help drive the clinical and commercial progress of ... of Stage IV metastatic melanoma," said Anthony Cataldo, ...
Cached Medicine Technology:Visual Healthcare Corp. Files Year-End Disclosure Statement 2Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise 2Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise 3Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise 4
(Date:3/5/2015)... East Providence, RI (PRWEB) March 05, 2015 ... for a third year in a row to support the ... cancer. The donation covered the purchase of the ‘Think ... Out’ game against Big East Conference opponent DePaul University at ... is pleased to continue our support of the PC women’s ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 In honor ... to shatter myths about drug and alcohol abuse in ... released a Fact Sheet with information on some of ... in 2010 by the National Institute on Drug Abuse, ... alcohol aims to counteract the illusions that teens and ...
(Date:3/5/2015)... 05, 2015 Califia Farms , ... the natural products coffee drinks category[1], today unveils its ... West in Anaheim, Calif. Concentrated Cold Brew (CCB) ... Café, which democratizes the next wave of the coffee-taste ... need to become their own baristas. , Califia ...
(Date:3/5/2015)... New York, NY (PRWEB) March 05, 2015 ... NY orthopedic Surgeon ( http://www.orthopedicsurgeonnyc.com ) has been named ... in the New York Metro area. Dr. Glashow has ... in its authoritative guide to the top specialty care ... 2015. , The prestigious Castle Connolly program, which carefully ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Nutrition Leaders, ... products, is pleased to offer reformulated Millennium 500 Creatine ... Millennium 500 is a German grade creatine supplement that ... promote muscle recovery, and aid with overall strength gains ... that acts as a reserve energy source in the ...
Breaking Medicine News(10 mins):Health News:RIMI Teams Up with PC Women’s Basketball in the Fight Against Breast Cancer 2Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4Health News:Dr. Jonathan Glashow, NYC Orthopedic Surgeon, Named Top Doctor: New York Metro Area 2Health News:Nutrition Leaders Offers Reformulated Millennium 500 German Grade Creatine 2
... a study done by Kate Rittenhouse-Olson, Ph.D., the monoclonal antibody ... shown to extend// significantly the survival of mice with human ... antibody inhibits the cancer's spread to the lungs in the ... study were published in the November 2006 issue of Journal ...
... of height which happens as people catch up with age is ... which could have major repercussions on health, increasing the chances of ... of about 3 centimeters or more in height of men as ... compared to men who lose less than a centimeter. This risk ...
... Researchers from University of Queensland believe that the conotoxins ... treatment for sufferers from chronic pain//. This treatment could ... ,Researchers say that the toxin, snail uses ... the severe side effects usually caused by other pain ...
... say that they are not abandoning their quest of finding ... the death of new cholesterol drugs manufactured// by Pfizer. Reducing ... cardiology in recent years, but boosting its counterpart, HDL, also ... market the new drug with Lipitor, a cholesterol-lowering statin that ...
... will now be made more easily available to critically ill ... proposition that will enable patients// who are extremely ill to ... other options. ,The FDA has announced that they ... drugs to be made available to needy individuals .They will ...
... nosed, bleary- eyed Britons, relief from hay fever may ... pill, designed to prevent// allergic reactions like a running nose, itching ... ,The vaccine pill contains small amounts of Timothy grass pollen; main ... weeks before hay fever season. ,This pill follows the ...
Cached Medicine News:Health News:Survival of Mice With Human Breast Cancer Extended by Monoclonal Antibodies 2Health News:Revolutionary Pill Promises Relief for Hay Fever Sufferers 2
CCR Medical conventional laryngoscope handles....
... ,Developed for cardiopulmonary resuscitation and the ... Fastrach™ has been designed to facilitate blind ... The LMA Fastrach™ allows continuous ventilation between ... teams worldwide including NASA for its ease ...
Robertazzi Amber Latex Free Nasal Airways are manufactured from natural amber latex. Soft, flexible maximizing comfort....
... Available in even sizes 20-36F. Single use. ... patient comfort. The Latex-Free Robertazzi is the ... offering the best solution for latex sensitivity. ... offer a quality latex-free product as your ...
Medicine Products: